D.C. Week: Price Defends Budget Cuts for His Agency
(MedPage Today) -- Also: FDA declares war on Opana ER; conservative scholars blame culture for opioid mess (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 10, 2017 Category: Geriatrics Source Type: news
Mother sees hope amid opioid crisis
Five years ago, Emily Walden had never heard of the powerful prescription opioid Opana ER. Today, she is one of its biggest critics, and she sees the Food and Drug Administration's request this week that drugmaker Endo Pharmaceuticals pull the painkiller off the market as a sign of hope. (Source: CNN.com - Health)
Source: CNN.com - Health - June 9, 2017 Category: Consumer Health News Source Type: news
New FDA boss sends message on addictive opioids. Will this East Bay drug maker benefit?
In an apparent first step toward taking on the nation's opioid abuse epidemic, the Food and Drug Administration is asking Endo Pharmaceuticals to remove the opioid pain medication Opana ER from the market.
If Endo complies with the FDA's Thursday request, it could be a boon for Impax Laboratories Inc., the Hayward manufacturer of a generic form of Opana ER before the drug was reformulated by Endo.
“We are facing an opioid epidemic – a public health crisis — and we must take all necessary… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 9, 2017 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
New FDA boss sends message on addictive opioids. Will this East Bay drug maker benefit?
In an apparent first step toward taking on the nation's opioid abuse epidemic, the Food and Drug Administration is asking Endo Pharmaceuticals to remove the opioid pain medication Opana ER from the market.
If Endo complies with the FDA's Thursday request, it could be a boon for Impax Laboratories Inc., the Hayward manufacturer of a generic form of Opana ER before the drug was reformulated by Endo.
“We are facing an opioid epidemic – a public health crisis — and we must take all necessary… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 9, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news
A Look Back: Abandoned Painkiller Makes a Comeback
(MedPage Today) -- Backstory on Opana ER, which the FDA now wants off the market (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 9, 2017 Category: American Health Source Type: news
FDA asks drugmaker to stop selling opioid painkiller Opana ER
U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. (Source: CBC | Health)
Source: CBC | Health - June 9, 2017 Category: Consumer Health News Tags: News/Health Source Type: news
FDA wants opioid painkiller removed from market
The U.S. Food and Drug Administration, or FDA, Thursday requested Endo Pharmaceuticals remove its opioid pain medication Opana from the market due to risks. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 9, 2017 Category: Consumer Health News Source Type: news
FDA asks Endo to pull Opana from the market over concerns of abuse
The FDA asked Endo Pharmaceuticals (NSDQ:ENDP) to pull its opioid pain med, Opana ER, from the market, saying that the benefits of the abuse-deterrent drug no longer outweigh the risks.
The move marks the 1st time the federal regulatory watchdog has urged a company to remove an opioid painkiller due to concerns of abuse.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA asks Endo to pull Opana from the market over concerns of abuse appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Endo Pharmaceuticals Source Type: news
FDA Asks Maker of Opioid Painkiller Opana ER to Pull Drug from Market
Agency says the powerful medication's risk for abuse now outweighs any benefit Source: HealthDay Related MedlinePlus Pages: Medicines, Opioid Abuse and Addiction, Pain Relievers (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 9, 2017 Category: Consumer Health News Source Type: news
In a first, FDA asks drugmaker to yank an opioid from the market
FDA eyed role of Endo Pharmaceuticals' drug Opana ER in opioid epidemic (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 9, 2017 Category: Consumer Health News Source Type: news
FDA Asks Maker of Opioid Painkiller Opana ER to Pull Drug From Market
FRIDAY, June 9, 2017 -- Sales of reformulated Opana ER, a prescription opioid painkiller, should be halted in the United States, the U.S. Food and Drug Administration says.
In its request Thursday for Endo Pharmaceuticals to voluntarily withdraw... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2017 Category: General Medicine Source Type: news
FDA Requests Removal of Opana ER From Market
FDA Requests Removal of Opana ER for Risks Related to Abuse (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 9, 2017 Category: General Medicine Source Type: news
F.D.A. Asks Drug Maker to Stop Selling a Dangerous Opioid
The agency ’ s request about the drug, Opana ER, may signal a more aggressive approach against prescription opioids that are found to be widely abused. (Source: NYT Health)
Source: NYT Health - June 8, 2017 Category: Consumer Health News Authors: DENISE GRADY Tags: Drugs (Pharmaceuticals) Food and Drug Administration Endo Pharmaceuticals Holdings Inc Pain-Relieving Drugs Source Type: news
FDA orders drugmaker to stop selling opioid painkiller
Endo Pharmaceuticals received an FDA warning on Thursday to remove Opana ER from the market. It is the first time US regulators have asked for a firm to discontinue an opioid painkiller. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2017 Category: Consumer Health News Source Type: news
U.S. asks drug maker Endo to withdraw opioid amid abuse crisis
WASHINGTON (Reuters) - As the United States battles a growing opioid abuse crisis, the Food and Drug Administration on Thursday asked Endo International Plc to withdraw from the market its long-lasting opioid painkiller, Opana ER, sending Endo's shares down more than 12 percent. (Source: Reuters: Health)
Source: Reuters: Health - June 8, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
